| J9299 | Injection, nivolumab, 1 mg | 44,920 | $20 | $1.1M |
| J9271 | Injection, pembrolizumab, 1 mg | 23,600 | $40 | $1M |
| J0897 | Injection, denosumab, 1 mg | 9,120 | $20 | $173.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 500 | $150 | $74.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 660 | $100 | $67.6K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 840 | $80 | $63K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 470 | $120 | $55.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 220 | $130 | $29.1K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 70 | $190 | $13.8K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 190 | $60 | $10.9K |